Colin Stubberfield

2.1k total citations
30 papers, 1.4k citations indexed

About

Colin Stubberfield is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Colin Stubberfield has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Colin Stubberfield's work include Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Metabolism and Genetic Disorders (4 papers). Colin Stubberfield is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Metabolism and Genetic Disorders (4 papers). Colin Stubberfield collaborates with scholars based in United Kingdom, Sweden and United States. Colin Stubberfield's co-authors include Martin Pagé, Gerald M. Cohen, Brian G. Lake, S.D. Gangolli, Tim J.B. Gray, Edward A. McKenzie, John R. Foster, Alasdair C. Stamps, Karen Affleck and Paul Turner and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemical Journal.

In The Last Decade

Colin Stubberfield

29 papers receiving 1.4k citations

Peers

Countries citing papers authored by Colin Stubberfield

Since Specialization

Citations

This map shows the geographic impact of Colin Stubberfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Stubberfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Stubberfield more than expected).

Fields of papers citing papers by Colin Stubberfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Stubberfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Stubberfield. The network helps show where Colin Stubberfield may publish in the future.

Co-authorship network of co-authors of Colin Stubberfield

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Stubberfield. A scholar is included among the top collaborators of Colin Stubberfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Stubberfield. Colin Stubberfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Actively protective combinatorial analysis: A scalable novel method for detecting variants that contribute to reduced disease prevalence in high-risk individuals 2025 ·SHILAP Revista de lepidopterología ·(unknown), Sayoni Das, Keith Taylor, Colin Stubberfield, Ann Kinga Malinowski, Mark Strivens, (unknown)	1
2	A modified and enhanced atdc5 chondrogenesis model produces an articular-like phenotype 2014 ·Osteoarthritis and Cartilage ·(unknown), Lara Kevorkian, T.E. Swingler, (unknown), Colin Stubberfield, Adrian Moore, Jelena Gavrilović	2
3	Structure and Interactions of the Human Programmed Cell Death 1 Receptor 2013 ·Journal of Biological Chemistry ·Xiaoxiao Cheng, Václav Veverka, Anand Radhakrishnan, Lorna C. Waters, Frederick W. Muskett, (unknown), Jiandong Huo, Chao Yu, Edward J. Evans, Alasdair Leslie, Meryn Griffiths, Colin Stubberfield, Robert Griffin, Alistair J. Henry, Andreas Jansson, John E. Ladbury, Shinji Ikemizu, Mark D. Carr, Simon J. Davis	263
4	Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation 2009 ·Bioorganic & Medicinal Chemistry Letters ·John Porter, Andrew Payne, Ian Whitcombe, (unknown), Daniel Ford, Rachel A. Garlish, (unknown), Brian Hutchinson, Graham Trevitt, James M. A. Turner, (unknown), (unknown), Jeremy Davis, Colin Stubberfield	28
5	Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·John Porter, Andrew Payne, (unknown), Daniel Ford, Brian Hutchinson, Graham Trevitt, James M. A. Turner, (unknown), (unknown), Ian Whitcombe, Jeremy Davis, Colin Stubberfield	86
6	Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney, (unknown), Richard T. Buck, (unknown), David J. Phillips, D. I. C. SCOPES, (unknown), Martin Pagé, James M. Bennett, (unknown), Edward A. McKenzie, (unknown), Robert Felix, Colin Stubberfield, Paul R. Turner	59
7	2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney, (unknown), Richard T. Buck, (unknown), David W. Porter, D. I. C. SCOPES, (unknown), Martin Pagé, James M. Bennett, (unknown), Edward A. McKenzie, Colin Stubberfield, Paul R. Turner	42
8	Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1) 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael G. Orchard, (unknown), (unknown), Andrew N. Carr, David W. Porter, Paul Smith, D. I. C. SCOPES, David J. Haydon, Katherine A. Vousden, Colin Stubberfield, Kate Young, Martin Pagé	107
9	Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells 2003 ·Biochemical Journal ·Edward A. McKenzie, (unknown), (unknown), James M. Bennett, (unknown), Robert Felix, Paul Turner, Alasdair C. Stamps, David J. McMillan, (unknown), (unknown), (unknown), Daniel Snell, Darren J. Schofield, (unknown), Reid Townsend, J T Gallagher, Martin Pagé, Raj Parekh, Colin Stubberfield	102
10	Patel S, Turner PR, Stubberfield C, Barry E, Rohlff CR, Stamps A, McKenzie E, Young K, Tyson K, Terrett J, Box G, Eccles S, Page MJ. Hyaluronidase gene profiling and role of HYAL‐1 overexpression in an orthotopic model of prostate cancer. International Journal of Cancer 2002;97(4): 416–424. 2002 ·International Journal of Cancer ·(unknown), (unknown), Colin Stubberfield, (unknown), (unknown), Alasdair C. Stamps, Edward A. McKenzie, Kimberly Young, Kerry Tyson, Jon Terrett, G. Box, Sue Eccles, (unknown)	4
11	Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2 2001 ·Bioorganic & Medicinal Chemistry Letters ·Stuart Cockerill, Colin Stubberfield, Jeremy N. Stables, (unknown), Stephen B. Guntrip, Kathryn J. Smith, (unknown), Robert J. Shaw, Peter Topley, Lindy L. Thomsen, Karen Affleck, Amanda Jowett, D. Neil Hayes, (unknown), P.M. Woollard, David J. Spalding	63
12	Ura-status-dependent adhesion of Candida albicans mutants 2001 ·FEMS Microbiology Letters ·Judith M. Bain, Colin Stubberfield, Neil A. R. Gow	55
13	Hyaluronidase gene profiling and role of HYAL‐1 overexpression in an orthotopic model of prostate cancer 2001 ·International Journal of Cancer ·Sonal Patel, Paul R. Turner, Colin Stubberfield, (unknown), Christian Rohlff, Alasdair C. Stamps, Kerry Tyson, Jon Terrett, Gary Box, Suzanne A. Eccles, Martin Pagé	48
14	Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family Member 2000 ·Biochemical and Biophysical Research Communications ·Edward A. McKenzie, Kerry Tyson, Alasdair C. Stamps, Paul N. Smith, Paul Turner, Richard D. Barry, (unknown), Sonal Patel, (unknown), Colin Stubberfield, Jon Terrett, Martin Pagé	152
15	Applying proteomics to drug discovery 1999 ·Expert Opinion on Investigational Drugs ·Colin Stubberfield, Martin Pagé	5
16	Electrophoretic detection of chitinase isoenzymes using the PhastSystem 1993 ·Electrophoresis ·Jeffrey D. McBride, Colin Stubberfield, Dave J. Hayes	6
17	Pyridine Nucleotide Changes In Hepatocytes Exposed To Quinones 1990 ·Free Radical Research Communications ·Gerald M. Cohen, Colin Stubberfield	11
18	Interconversion of NAD(H) TO NADP(H) 1989 ·Biochemical Pharmacology ·Colin Stubberfield, Gerald M. Cohen	46
19	Nad+ depletion and cytotoxicity in isolated hepatocytes 1988 ·Biochemical Pharmacology ·Colin Stubberfield, Gerald M. Cohen	41
20	Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamster 1984 ·Toxicology and Applied Pharmacology ·Brian G. Lake, Tim J.B. Gray, John R. Foster, Colin Stubberfield, S.D. Gangolli	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact